Clinical trial
JADE - Clinical Research Platform on Treatment and Outcome in Patients With Hepatocellular or Cholangiocellular Cancer
NCT04510740 is registered in ClinicalTrials.gov with iOMEDICO AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- JADE - Clinical Research Platform on Treatment and Outcome in Patients With Hepatocellular or Cholangiocellular Cancer
- Lead sponsor
- iOMEDICO AG
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- August 9, 2020
- Completion date
- December 31, 2027
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cholangiocarcinoma, hepatocellular carcinoma (hcc)